Literature DB >> 17011914

Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up.

M E Edwards1, A Rotramel, T Beyer, M J Gaffud, G Djuricin, K Loviscek, C C Solorzano, R A Prinz.   

Abstract

BACKGROUND: Subjective symptoms such as decreased energy, chronic fatigue, and depression are associated with hyperparathyroidism. Studies have shown that these symptoms are improved during short-term follow-up after parathyroidectomy. This study evaluates the durability of this subjective improvement in quality-of-life symptoms in a large population of patients with follow-up greater than 1 year after operation.
METHODS: Between 2002 and 2005, 258 patients underwent parathyroidectomy, 100 (81 females and 19 males) of whom were available for this study. The patients were evaluated with a survey based on the Health Outcomes Institute Health Status Questionnaire. Some answers were quantified on a 1 to 6 scale, while others consisted of "yes" or "no" responses. Patients completed a questionnaire prior to parathyroidectomy and postoperatively at 1 month, 3 to 6 months, and 1 to 2 years or greater intervals. Statistical analysis was used to detect changes attributable to parathyroidectomy. A P value <.05 was considered statistically significant.
RESULTS: At 1-month follow-up, patients' perceptions of their overall health, energy level, and mood significantly improved. At 6-month follow-up, significant improvements in muscle strength, health, endurance, and relief of anxiety were documented. At the interval of 1 to 2 years, overall health, energy level, endurance, and relief of anxiety were improved. There was no significant decrement in the quality of life in these patients after parathyroidectomy.
CONCLUSIONS: Parathyroidectomy for hyperparathyroidism is associated with significant lasting improvement in subjective symptoms. The potential durable improvement in these quality-of-life symptoms is a valid indication for parathyroidectomy.

Entities:  

Mesh:

Year:  2006        PMID: 17011914     DOI: 10.1016/j.surg.2006.06.016

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism.

Authors:  Dominika Babińska; Marcin Barczyński; Tomasz Stefaniak; Tomasz Osęka; Anna Babińska; Dariusz Babiński; Krzysztof Sworczak; Andrzej J Lachiński; Wojciech Nowak; Zbigniew Sledziński
Journal:  Langenbecks Arch Surg       Date:  2011-12-08       Impact factor: 3.445

2.  Risk factors for treatment failure in surgery for primary hyperparathyroidism: the impact of change in surgical strategy and training procedures.

Authors:  Anders Rørbæk Madsen; Lars Rasmussen; Christian Godballe
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-05       Impact factor: 2.503

3.  Surgical cure of primary hyperparathyroidism ameliorates gastroesophageal reflux symptoms.

Authors:  James Norman; Douglas Politz; Jose Lopez; Deva Boone; Alexander Stojadinovic
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

4.  Video-assisted bilateral neck exploration in patients with primary hyperparathyroidism and failed localization studies.

Authors:  Pier F Alesina; Reyaz M Singaporewalla; Martin K Walz
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

Review 5.  Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis.

Authors:  N Singh Ospina; S Maraka; R Rodriguez-Gutierrez; A E Espinosa de Ycaza; S Jasim; M Gionfriddo; A Castaneda-Guarderas; J P Brito; A Al Nofal; P Erwin; R Wermers; V Montori
Journal:  Osteoporos Int       Date:  2016-08-25       Impact factor: 4.507

Review 6.  What symptom improvement can be expected after operation for primary hyperparathyroidism?

Authors:  Nadine R Caron; Janice L Pasieka
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 7.  Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. long-term results.

Authors:  Douglas L Fraker; Hasly Harsono; Robert Lewis
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

8.  Current status and treatment of primary hyperparathyroidism.

Authors:  Dina M Elaraj; Orlo H Clark
Journal:  Perm J       Date:  2008

9.  Surgery did not improve the subjective neuropsychological symptoms of patients with incidentally detected mild primary hyperparathyroidism.

Authors:  Kiyoaki Tsukahara; Iwao Sugitani; Yoshihide Fujimoto; Kazuyoshi Kawabata
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-14       Impact factor: 2.503

Review 10.  Severe bone disease caused by primary hyperparathyroidism: a case report and review of the literature.

Authors:  Yu Wang; Jie Liu
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.